| [April 29, 2016] |
 |
Actinic (Solar) Keratosis Pipeline Report H1 2016 - Review of 17 Companies & Drug Profiles - Research and Markets
Research and Markets has announced the addition of the "Actinic
(Solar) Keratosis - Pipeline Review, H1 2016" report to their
offering.
This report provides comprehensive information on the therapeutic
development for Actinic (Solar) Keratosis, complete with comparative
analysis at various stages, therapeutics assessment by drug target,
mechanism of action (MoA), route of administration (RoA) and molecule
type, along with latest updates, and featured news and press releases.
It also reviews key players involved in the therapeutic development for
Actinic (Solar) Keratosis and special features on late-stage and
discontinued projects.
The report enhances decision making capabilities and help to create
effective counter strategies to gain competitive advantage. It
strengthens R&D pipelines by identifying new targets and MOAs to produce
first-in-class and best-in-class products.
Key Topics Covered:
-
Itroduction
-
Actinic (Solar) Keratosis Overview
-
Therapeutics Development
-
Pipeline Products for Actinic (Solar) Keratosis - Overview
-
Pipeline Products for Actinic (Solar) Keratosis - Comparative Analysis
-
Actinic (Solar) Keratosis - Therapeutics under Development by Companies
-
Actinic (Solar) Keratosis - Therapeutics under Investigation by
Universities/Institutes
-
Actinic (Solar) Keratosis Products Glance
-
Late Stage Products
-
Clinical Stage Products
-
Early Stage Products
-
Actinic (Solar) Keratosis - Products under Development by Companies
-
Actinic (Solar) Keratosis - Products under Investigation by
Universities/Institutes
-
Actinic (Solar) Keratosis - Companies Involved in Therapeutics
Development
-
3M (News - Alert) Drug Delivery Systems
-
Athenex, Inc.
-
Biofrontera AG
-
Digna Biotech, S.L.
-
Dolorgiet Gmbh & Co. Kg
-
Foamix Pharmaceuticals Ltd.
-
G&E Herbal Biotechnology Co., Ltd.
-
Galderma S.A.
-
Laboratories Ojer Pharma S.L.
-
LEO Pharma A/S
-
Novartis AG
-
Novelix Pharmaceuticals, Inc.
-
Oncology Research International Limited
-
Promius Pharma, LLC
-
SkyePharma Plc
-
Spherium Biomed S.L.
-
Valeant Pharmaceuticals International, Inc.
For more information visit http://www.researchandmarkets.com/research/b2hm9x/actinic_solar
View source version on businesswire.com: http://www.businesswire.com/news/home/20160429005581/en/
[ Back To TMCnet.com's Homepage ]
|
